Agent for recovery: the opportunity for enhancing social inclusion afforded by prolonged-release buprenorphine formulations

HS Tayside0 个研究点目标入组 57 人开始时间: 2022年4月28日最近更新: 2024年2月19日

试验速览

暂无简介。

•1. Adult (aged 18 years or over) males and females
•2. History of problematic substance abuse
•3. Treated in NHS Tayside with either Buvidal (prolonged-release buprenorphine) or sublingual/oral lyophilisate buprenorphine
•4. A member of the multidisciplinary alcohol and drug recovery service team in NHS Tayside (staff participant only)
•5. People of any ethnic origin who are able to speak English and are willing to talk about and reflect on their experiences with the phenomenon under study
•6. Willing to have the semi-structured interviews audio recorded
•7. Able to give informed consent

•1. Individuals will not be enrolled on the study if they are participating in the clinical phase of another interventional study or have done so within the last 30 days
•2. Individuals who are participating in the follow-up phase of another interventional trial/study, or who are enrolled in an observational study, will be co-enrolled where the CIs of each study agree that it is appropriate

发起方

HS Tayside